Patent · US Expired

4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them

US7078407B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2002
Grant dateJul 18, 2006
Priority date
Expiry dateJun 22, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them. More particularly, it relates to 4-hydroxycinnamamide derivatives showing superior antioxidant activity compared to the known antioxidant compounds, their pharmaceutically acceptable salt, and pharmaceutical compositions containing them. It can be usefully used in treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkin's disease, dementia and Huntinton's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.